ATNM vs NDAQ · rev $35.0M vs P/E 41, rev $2.53B
Actinium Pharmaceuticals Inc (ATNM) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
ATNM currently screens at market cap $33.9M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the ATNM and NDAQ stock pages for the full models.
Not investment advice.